An accomplished asset manager and biotechnology investor with many years of experience, Dr. Lindsay Rosenwald currently serves as a co-founder of Opus Point Partners. Over the years, Dr. Lindsay Rosenwald has played an integral role in the development of treatments for several diseases, including schizophrenia. A complex psychological disorder with many different symptoms, schizophrenia often responds to anti-psychotic medications such as fluphenazine, haloperidol, chlorpromazine, and perhpenazine.

1. By Dr. Lindsay Rosenwald

2. An accomplished asset manager and
biotechnology investor with many years of
experience, Dr. Lindsay Rosenwald currently
serves as a co-founder of Opus Point Partners.
Over the years, Dr. Lindsay Rosenwald has played
an integral role in the development of treatments
for several diseases, including schizophrenia. A
complex psychological disorder with many
different symptoms, schizophrenia often
responds to anti-psychotic medications such as
fluphenazine, haloperidol, chlorpromazine, and
perhpenazine.

3. In addition to pharmaceutical treatments,
schizophrenia usually responds to some form of
psychosocial treatment, which helps patients to cope
with the everyday symptoms of the disorder. In
particular, services such as family education and
integrated treatment for co-occurring substance
abuse helps individuals and families to understand
the disorder and make lifestyle changes to
accommodate it. Many patients experience success
with cognitive behavioral therapy, which primarily
focuses on managing symptoms and reducing the
risk of relapse. In recent years, self-help groups have
emerged as a way for people with schizophrenia to
find support in their struggle and work together to
overcome the disease.